Fairvalue-Calculator Fairvalue-Calculator
EN DE

Laboratorios Richmond S.A. (RICH) Fair Value & Analysis

Healthcare · AR · Market cap 131B ARS

Price1,595 ARS
Fair Value2,155 ARS
Upside+35.1%
Quality95/100
Evidence: Medium Range 1,006 ARS – 2,801 ARS

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Laboratorios Richmond S.A. (RICH) currently trades at 1,595 ARS, while our model-based Fair Value estimate is 2,155 ARS — implying the stock looks roughly 35.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1827% Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81%

Frequently asked questions

Is Laboratorios Richmond S.A. (RICH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,155 ARS versus a price of 1,595 ARS — about +35% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RICH?
Our 21-model fair value for Laboratorios Richmond S.A. is 2,155 ARS (as of Jun 24, 2026), built from audited fundamentals. The current price is 1,595 ARS.
What is the quality score of RICH?
Laboratorios Richmond S.A. has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.